$6.470
0.000 (0.00%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
¿Debería comprar acciones de Sinovac Biotech Ltd?
Sinovac Biotech Ltd is currently not a strong buy due to its negative financial metrics, including a forward P/E ratio of 357.14, indicating high valuation concerns. While the company has declared a special cash dividend of $55 per share, which could enhance shareholder confidence, the overall financial performance shows significant risks, particularly with a negative price-to-earnings ratio of -1.87. The main risk is the high forward P/E ratio, suggesting that the stock may be overvalued at its current price.
SVA cerró en $6.47 el Friday, tras subir 0.00%
Sinovac Biotech Ltd (SVA) last closed at $6.47, gaining +0.00%. These facts feed the 1-day and 1-week SVA price prediction above.
Factores de la previsión
Los factores de la previsión de Sinovac Biotech Ltd (SVA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Análisis de estacionalidad de SVA
Historically the probability of a positive September return for SVA is 0.00%. January offers the highest probability of a positive month at 0.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.